Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00500331
First received: January 24, 2007
Last updated: March 21, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 22, 2009
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):